Cover Image
市場調查報告書

內臟器官保存解決方案市場 - 全球產業分析、規模、市場佔有率、成長、趨勢及預測

Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 295919
出版日期 內容資訊 英文 80 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
內臟器官保存解決方案市場 - 全球產業分析、規模、市場佔有率、成長、趨勢及預測 Organ Preservation Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年02月06日 內容資訊: 英文 80 Pages
簡介

本報告將內臟器官保存解決方案的全球市場以全球規模及北美,歐洲、亞太地區、其他地區的各地區、各解決方案及保存技術進行市場區隔化,提供2012年為基準從2011年到2019年的銷售額市場規模分析,上述每市場區隔從2013年到2019年的年複合成長率。推動市場要素,阻礙因素及市場機會。2012年的各地區的市場魅力分析,波特的全球市場五力分析,主要企業的市場佔有率,競爭情形和主要企業簡介,為您概述為以下內容。

第1章 序

  • 報告的說明
  • 市場區隔
  • 調查方法

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 推動市場要素
    • 全球人口高齡化
    • 技術的進步
    • 給付方案增加
    • 每人醫療支出的增加
  • 阻礙市場要素
    • 器官捐贈者的不足
    • 高的手術費用
  • 市場機會
    • 跟研究確實保持基本客群的機關和醫療機關的聯合
  • 波特的全球內臟器官保存的解決方案市場五力分析
    • 供給者談判力
    • 買主談判力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭關係
  • 市場魅力分析:全球內臟器官保存解決方案市場,各地區

第4章 全球內臟器官保存解決方案市場,各解決方案(一百萬美元)

  • 概要
  • Viaspan
  • Custodiol HTK-(組氨酸-色氨酸-酮戊二酸) 解決方案
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • Human bioSystem (HBS)解決方案
  • siRNA移植解決方案
  • 其他

第5章 全球內臟器官保存解決方案市場,各保存技術(一百萬美元)

  • 概要
  • 低體溫灌流保存(HPP)
  • 靜態冷藏(SCS)
  • 其他

第6章 全球內臟器官保存解決方案市場,各地區(一百萬美元)

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 全球其他地區(ROW)

第7章 競爭情形

  • 各主要企業市場佔有率(%)

第8章 建議

  • 跟醫療保健服務、供應商的長期契約
  • 擴大通網的幅度
  • 產品的創新

第9章 企業簡介

  • 21st Century Medicine
  • BioLife Solutions, Inc.
  • BioTime, Inc.
  • Bristol-Myers Squibb
  • Claris Lifesciences Limited
  • CryoLife, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Lifeline Scientific
  • Teva Pharmaceutical Industries Ltd.
  • ToleroTech, Inc.
  • XVIVO Perfusion AB
目錄

Title: Organ Preservation Solutions Market (By Solutions - Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and Others, and By Preservation Techniques- Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

This report studies the global organ preservation solutions market based on the various solutions available in the market in which organs are preserved, type of preservation techniques used and the major geographic markets. The global market for organ preservation solutions has been segmented into nine major solutions that include Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor). On the basis of preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques).

Geographically, the report studies the global market with respect to four main regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecasts in terms of revenue (USD million) for the period 2011 to 2019, considering 2012 as the base year, have been provided for each solution type, technique type and geographic region. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments.

The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. This section also covers a market attractiveness analysis (by geography) for the year 2012 and Porter's five forces analysis for the global organ preservation solutions market. Market share (%) for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. Also, the report includes company profiles of key players operating in various segments of the market. Each company profile includes the business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the prominent players in the organ preservation solutions market that have been profiled in this report include Dr. Franz Köhler Chemie GmbH, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, BioLife Solutions, Inc., XVIVO Perfusion AB and ToleroTech, Inc.

The global organ preservation solutions market has been segmented as below:

Organ Preservation Solutions Market, by Solution

  • Viaspan
  • Custodiol HTK (Histidine-Tryptophan-Ketoglutarate)
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • Human bioSystem (HBS) Solution
  • siRNA Transplant Solutions
  • Others

Organ Preservation Solutions Market, by Preservation Technique

  • Hypothermic Perfusion Preservation (HPP)
  • Static Cold Storage (SCS)
  • Others

Organ Preservation Solutions Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

Chapter 3 - Market Overview

  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Aging global population
      • 3.2.1.1. Global rate of aging population
    • 3.2.2. Technological advancements
    • 3.2.3. Increasing reimbursement scenario
    • 3.2.4. Increase in per capita healthcare expenditure
  • 3.3. Market Restraints
    • 3.3.1. Lack of organ donors
      • 3.3.1.1. Widening Gap Between Patients Receiving Organ Transplants and Number of Donors in the U.S. (1998 - 2010)
    • 3.3.2. High cost of procedure
  • 3.4. Market Opportunities
    • 3.4.1. Collaboration with research-oriented organizations and medical institutes to ensure retention of customer base
  • 3.5. Porter's Five Force Analysis for the Global Organ Preservation Solutions Market
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat of substitutes
    • 3.5.4. Threat of new entrants
    • 3.5.5. Competitive rivalry
  • 3.6. Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography

Chapter 4 - Global Organ Preservation Solutions Market, By Solution, 2011 - 2019 (USD Million)

  • 4.1. Overview
    • 4.1.1. Global Organ Preservation Solutions Market Revenue, by Solution Type, 2011 - 2019 (USD Million)
    • 4.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
  • 4.2. Viaspan
    • 4.2.1. Global Viaspan Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Custodiol HTK - (Histidine-Tryptophan-Ketoglutarate) Solution
    • 4.3.1. Global Custodiol Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Renograf
    • 4.4.1. Global Renograf Market Revenue, 2011 - 2019 (USD Million)
  • 4.5. Hypothermosol
    • 4.5.1. Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)
  • 4.6. Perfadex
    • 4.6.1. Global Perfadex Market Revenue, 2011 - 2019 (USD Million)
  • 4.7. Lifor
    • 4.7.1. Global Lifor Market Revenue, 2011 - 2019 (USD Million)
  • 4.8. Human bioSystem (HBS) Solution
    • 4.8.1. Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)
  • 4.9. siRNA Transplant Solution
    • 4.9.1. Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)
  • 4.10. Others
    • 4.10.1. Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Organ Preservation Solutions Market, By Preservation Technique, 2011 - 2019 (USD Million)

  • 5.1. Overview
    • 5.1.1. Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million)
    • 5.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 & 2019 (Value %)
  • 5.2. Hypothermic Perfusion Preservation (HPP)
    • 5.2.1. Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)
  • 5.3 Static Cold Storage (SCS)
    • 5.3.1. Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Others
    • 5.4.1. Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Global Organ Preservation Solutions Market, By Geography, 2011 - 2019 (USD Million)

  • 6.1. Overview
    • 6.1.1. Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million)
    • 6.1.2. Comparative Analysis: Global Organ Preservation Solutions Market, by Geography, 2012 & 2019 (Value %)
  • 6.2. North America
    • 6.2.1. North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Deceased Donation Rate (Per Million of Population), by Country, 2011
    • 6.3.2. Europe Organ Donation and Transplantation Data, 2011
    • 6.3.3. Donation and Transplantation Number Per European Country, 2011
    • 6.3.4. Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Organ Donation and Transplantation Data for Japan (2009 - 2013)
    • 6.4.2. Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Competitive Landscape

  • 7.1 Market Share by Key Players, 2012 (%)

Chapter 8 - Recommendations

  • 8.1. Long term contracts with healthcare service providers
  • 8.2. Broadening of distribution network
  • 8.3. Product innovation

Chapter 9 - Company Profiles

  • 9.1. 21st Century Medicine
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio
  • 9.2. BioLife Solutions, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. BioTime, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
    • 9.3.5. Recent Developments
  • 9.4. Bristol-Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Claris Lifesciences Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. CryoLife, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. Dr. Franz Köhler Chemie GmbH
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Business Strategies
  • 9.8. Lifeline Scientific
    • 9.8.1. Company Profile
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. Teva Pharmaceutical Industries Ltd.
    • 9.9.1. Company Profile
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. ToleroTech, Inc.
    • 9.10.1. Company Profile
    • 9.10.2. Product Portfolio
    • 9.10.3. Business Strategies
  • 9.11. XVIVO Perfusion AB
    • 9.11.1. Company Overview
    • 9.11.2. Financial Overview
    • 9.11.3. Product Portfolio
    • 9.11.4. Business Strategies

List of Figures

  • FIG. 1: Organ Preservation Solutions Market Segmentation
  • FIG. 2: Global Organ Preservation Solutions Market, by Solution, 2012 (USD Million)
  • FIG. 3: Global Organ Preservation Solutions Market, by Preservation Technique, 2012 (USD Million)
  • FIG. 4: Global Rate of Aging Population
  • FIG. 5: Gap Between Organ Transplant and Donors in the U.S. (1998 - 2010)
  • FIG. 6: Porter's Five Force Analysis: Global Organ Preservation Solutions Market
  • FIG. 7: Market Attractiveness Analysis: Global Organ Preservation Solutions Market, by Geography
  • FIG. 8: Comparative Analysis: Global Organ Preservation Solutions Market, by Solution Type, 2012 & 2019 (Value %)
  • FIG. 9: Global Viaspan Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Custodiol Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Renograf Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Hypothermosol Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Perfadex Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Lifor Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Global HBS Solution Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Global siRNA Transplant Solution Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: Global Other Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: Comparative Analysis: Global Organ Preservation Solution Market, by Preservation Technique, 2012 & 2019 (Value %)
  • FIG. 19: Global Hypothermic Perfusion Preservation Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20: Global Static Cold Storage Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21: Global Other Preservation Techniques Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22: Comparative Analysis: Global Organ Preservation Solution Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 23: North America Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24: Europe Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25: Asia Pacific Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 26: RoW Organ Preservation Solutions Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 27: Market Share by Key Players, 2012 (%)
  • FIG. 28: Annual Revenue: BioLife Solutions, Inc., 2010 - 2012 (USD Million)
  • FIG. 29: Annual Revenue: BioTime Inc., 2010 - 2012 (USD Million)
  • FIG. 30: Annual Revenue: Bristol-Myers Squibb, 2010 - 2012 (USD Million)
  • FIG. 31: Annual Sales: Claris Lifesciences Ltd., 2010 - 2012 (USD Million)
  • FIG. 32: Annual Revenue: CryoLife, Inc., 2010 - 2012 (USD Million)
  • FIG. 33: Annual Revenue: Lifeline Scientific, 2010 - 2012 (USD Million)
  • FIG. 34: Annual Revenue: Teva Pharmaceutical Industries Ltd., 2010 - 2012 (USD Million)
  • FIG. 35: Annual Sales: XVIVO Perfusion AB, 2010 - 2012 (USD Million)

List of Tables

TABLE 1: Market Snapshot: Global Organ Preservation Solutions Market TABLE 2: Global Organ Preservation Solutions Market Revenue, by Solution, 2011 - 2019 (USD Million) TABLE 3: Global Organ Preservation Solutions Market Revenue, by Preservation Technique, 2011 - 2019 (USD Million) TABLE 4: Global Organ Preservation Solutions Market Revenue, by Geography, 2011 - 2019 (USD Million) TABLE 5: Organ Donation and Transplantation Data for Japan (2009 - 2013)

Back to Top